Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

MoonLake Immunotherapeutics

MLTX
Current price
48.83 USD -3.15 USD (-6.06%)
Last closed 52.5 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 265 448 704 USD
Yield for 12 month +14.25 %
1Y
3Y
5Y
10Y
15Y
MLTX
21.11.2021 - 28.11.2021

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland. Address: Dorfstrasse 29, Zug, Switzerland, 6300

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

71.5 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-13 158 USD

Last Year

-12 358 USD

Current Quarter

Last Quarter

-28 112 USD

Key Figures MLTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -78 346 824 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -9.32 %
PEG Ratio
Return On Equity TTM -11.32 %
Wall Street Target Price 71.5 USD
Revenue TTM
Book Value 8.2 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.87 USD
Diluted Eps TTM -0.87 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MLTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MLTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MLTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -41.5328
Price Book MRQ 6.262

Financials MLTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MLTX

For 52 weeks

35.78 USD 64.98 USD
50 Day MA 49.35 USD
Shares Short Prior Month 7 971 306
200 Day MA 47.16 USD
Short Ratio 17.43
Shares Short 8 149 387
Short Percent 31.55 %